ENDO INTERNATIONAL for ENDO INTERNATIONAL
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Taxation/Internal Revenue Code TAX
Issues relating to incentives for life science research H.R. 523/S. 232--Protect Medical Innovation Act of 2013
| Lobbyist | Covered position, as disclosed |
|---|---|
| BRENT J FISK | — |
| JAMES BRIAN MUNROE | — |
| CANDIE PHIPPS | — |
Copyright/Patent/Trademark CPT
Oversight of implementation of the America Invents Act. Issues realting to patent settlements
| Lobbyist | Covered position, as disclosed |
|---|---|
| BRENT J FISK | — |
| JAMES BRIAN MUNROE | — |
| CANDIE PHIPPS | — |
Health Issues HCR
Issues relating to bioequivalence and related administrative procedures Issues relating to prescription drug abuse Issues relating to incentives for tamper-resistant formulations H.R. 486--Stop Tampering of Prescription Pills Act of 2013Issues relating to Medicare Part D rebates Issues relating to health information technology
| Lobbyist | Covered position, as disclosed |
|---|---|
| BRENT J FISK | — |
| JAMES BRIAN MUNROE | — |
| CANDIE PHIPPS | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.